Benchmarking Medical Information Services Beyond the Unsolicited Requests: A phactMI Benchmarking Survey.

IF 2 4区 医学 Q4 MEDICAL INFORMATICS
Michael J DeLuca, Rena Rai, Kirtida Pandya, Lillian Chavez, Prachee Satpute, Michael Rocco, Parul Shah, Jen Multari, Michael Cuozzo, Evelyn R Hermes-DeSantis
{"title":"Benchmarking Medical Information Services Beyond the Unsolicited Requests: A phactMI Benchmarking Survey.","authors":"Michael J DeLuca, Rena Rai, Kirtida Pandya, Lillian Chavez, Prachee Satpute, Michael Rocco, Parul Shah, Jen Multari, Michael Cuozzo, Evelyn R Hermes-DeSantis","doi":"10.1007/s43441-025-00787-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Medical Information has a strategic role that extends beyond inquiry management. The Pharma Collaboration for Transparent Medical Information (phactMI™) benchmarking survey of 35 US pharmaceutical companies was conducted to describe the current landscape and future opportunities of other services Medical Information could provide.</p><p><strong>Methods: </strong>In July 2023, an electronic survey containing 57 closed and open-ended questions was distributed to phactMI member companies. The survey questions addressed demographics, medical review, development of materials, training, patient services, insights, and awareness.</p><p><strong>Results: </strong>Medical Information is a significant contributor to the medical review of promotional healthcare provider materials (51%), patient materials (52%), and non-promotional medical materials (45%). Medical Information ensures the accuracy of medical information, fact checks and validates claim accuracy. Fifty percent of the respondents are responsible for reviewing and/or contributing to Medical Affairs material for Field Medical. Additionally, Medical Information trains both Field Medical and Sales teams on the Medical Information function, and to a lesser extent, disease state information. The majority (75%) of Medical Information Departments offer patient information. The vast majority (85%) produce and identify insights. Medical Directors, Field Medical, and Scientific Communications/ Publications often receive shared insights. Fewer individuals integrate insights with Field Medical and Medical Directors. Since 2018, Medical Information activities have seen a rise in advisory board presentations, insights reporting, publications, competitive intelligence, disease state education, surveillance, pathway submission, and labelling activities. Building awareness is still an important aspect of Medical Information and most focus on the development of their Medical Information website.</p><p><strong>Conclusion: </strong>The essential roles and activities of Medical Information Departments support products at every stage. Medical Information participates with multiple functions in evaluating medical materials and there is a growing trend of including Medical Information in the development and review of Medical Affairs materials. Medical Information has expanded its participation in pathway submissions, publications, and labeling activities. This benchmark for Medical Information can provide a potential best practice template for activities. For the future, the three areas to prioritize are: increasing the strategic value and KPIs of Medical Information, integrating and overseeing AI technology in the insights process, and improving internal visibility.</p>","PeriodicalId":23084,"journal":{"name":"Therapeutic innovation & regulatory science","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic innovation & regulatory science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s43441-025-00787-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Medical Information has a strategic role that extends beyond inquiry management. The Pharma Collaboration for Transparent Medical Information (phactMI™) benchmarking survey of 35 US pharmaceutical companies was conducted to describe the current landscape and future opportunities of other services Medical Information could provide.

Methods: In July 2023, an electronic survey containing 57 closed and open-ended questions was distributed to phactMI member companies. The survey questions addressed demographics, medical review, development of materials, training, patient services, insights, and awareness.

Results: Medical Information is a significant contributor to the medical review of promotional healthcare provider materials (51%), patient materials (52%), and non-promotional medical materials (45%). Medical Information ensures the accuracy of medical information, fact checks and validates claim accuracy. Fifty percent of the respondents are responsible for reviewing and/or contributing to Medical Affairs material for Field Medical. Additionally, Medical Information trains both Field Medical and Sales teams on the Medical Information function, and to a lesser extent, disease state information. The majority (75%) of Medical Information Departments offer patient information. The vast majority (85%) produce and identify insights. Medical Directors, Field Medical, and Scientific Communications/ Publications often receive shared insights. Fewer individuals integrate insights with Field Medical and Medical Directors. Since 2018, Medical Information activities have seen a rise in advisory board presentations, insights reporting, publications, competitive intelligence, disease state education, surveillance, pathway submission, and labelling activities. Building awareness is still an important aspect of Medical Information and most focus on the development of their Medical Information website.

Conclusion: The essential roles and activities of Medical Information Departments support products at every stage. Medical Information participates with multiple functions in evaluating medical materials and there is a growing trend of including Medical Information in the development and review of Medical Affairs materials. Medical Information has expanded its participation in pathway submissions, publications, and labeling activities. This benchmark for Medical Information can provide a potential best practice template for activities. For the future, the three areas to prioritize are: increasing the strategic value and KPIs of Medical Information, integrating and overseeing AI technology in the insights process, and improving internal visibility.

超越主动请求的医疗信息服务基准:一项phactMI基准调查。
目的:医学信息具有超越查询管理的战略作用。透明医疗信息制药合作(phactMI™)对35家美国制药公司进行了基准调查,以描述医疗信息可以提供的其他服务的现状和未来机会。方法:于2023年7月向phactMI会员企业发放了一份包含57个封闭式和开放式问题的电子调查。调查问题涉及人口统计、医学审查、材料开发、培训、患者服务、见解和意识。结果:医学信息对医疗保健提供者宣传性材料(51%)、患者宣传性材料(52%)和非宣传性医疗材料(45%)的医学审查有重要贡献。医疗信息确保医疗信息的准确性,事实检查和验证索赔的准确性。50%的答复者负责审查和(或)向战地医疗提供医疗事务材料。此外,医疗信息还对现场医疗团队和销售团队进行医疗信息功能培训,并在较小程度上培训疾病状态信息。大多数(75%)的医疗信息部门提供患者信息。绝大多数(85%)产生并确定见解。医疗主任、现场医疗和科学传播/出版物经常收到共同的见解。很少有人将见解与现场医疗和医疗主管结合起来。自2018年以来,医疗信息活动在咨询委员会演讲、见解报告、出版物、竞争情报、疾病状态教育、监测、途径提交和标签活动方面有所增加。建立意识仍然是医学信息的一个重要方面,也是医学信息网站开发的重中之重。结论:医疗信息部门在产品的各个阶段都扮演着重要的角色和活动。《医学信息》在医学文献评价中发挥着多种作用,将《医学信息》纳入到医学文献的开发和评审中有越来越大的趋势。《医学信息》扩大了对途径提交、出版物和标签活动的参与。此医疗信息基准可以为活动提供潜在的最佳实践模板。对于未来,优先考虑的三个领域是:提高医疗信息的战略价值和kpi,在洞察过程中集成和监督人工智能技术,以及提高内部可见性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic innovation & regulatory science
Therapeutic innovation & regulatory science MEDICAL INFORMATICS-PHARMACOLOGY & PHARMACY
CiteScore
3.40
自引率
13.30%
发文量
127
期刊介绍: Therapeutic Innovation & Regulatory Science (TIRS) is the official scientific journal of DIA that strives to advance medical product discovery, development, regulation, and use through the publication of peer-reviewed original and review articles, commentaries, and letters to the editor across the spectrum of converting biomedical science into practical solutions to advance human health. The focus areas of the journal are as follows: Biostatistics Clinical Trials Product Development and Innovation Global Perspectives Policy Regulatory Science Product Safety Special Populations
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信